» Authors » Scott M Bradfield

Scott M Bradfield

Explore the profile of Scott M Bradfield including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 93
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Augustin E, Indelicato D, Bradley J, Fortune 4th E, Dagan R, Morris C, et al.
Pediatr Blood Cancer . 2025 Feb; :e31571. PMID: 39948319
Background: In contrast to adult salivary gland tumors, our institutional guidelines utilize lower radiation doses, smaller target margins, and proton therapy (PT) to minimize radiation to children's developing skull base...
2.
Dupuis L, Vettese E, Grimes A, Beauchemin M, Klesges L, Baggott C, et al.
JAMA . 2024 Nov; 332(23):1981-1991. PMID: 39535768
Importance: Pediatric patients with cancer commonly experience severely bothersome symptoms. The effectiveness of routine symptom screening with symptom feedback and symptom management care pathways is unknown. Objective: To determine whether...
3.
Chalfant V, Riveros C, Bechtel A, Bradfield S, Stec A
J Pediatr Hematol Oncol . 2023 Nov; 46(1):33-38. PMID: 37910818
Background: Socioeconomic disparities exist in pediatric patients with hematologic malignancies, leading to suboptimal survival rates. Social determinants of health impact health outcomes, and in children, they may not only lead...
4.
Vettese E, Sherani F, King A, Yu L, Aftandilian C, Baggott C, et al.
BMC Cancer . 2023 Apr; 23(1):350. PMID: 37069510
Background: There is substantial heterogeneity in symptom management provided to pediatric patients with cancer. The primary objective was to describe the adaptation process and specific adaptation decisions related to symptom...
5.
Chalfant V, Riveros C, Bradfield S, Stec A
Lancet Reg Health Am . 2023 Mar; 20:100454. PMID: 36875264
Background: Studies reporting on the impact of social determinants of health on childhood cancer are limited. The current study aimed to examine the relationship between health disparities, as measured by...
6.
Metts J, Harrington B, Salman E, Bradfield S, Flanary J, Mosha M, et al.
Childs Nerv Syst . 2022 Mar; 38(5):919-928. PMID: 35260913
Purpose: Children with relapsed/refractory central nervous system (CNS) tumors require novel combinations of therapies. Irinotecan and temozolomide (IT) is a frequently used therapy with an established toxicity profile. Bevacizumab is...
7.
Indelicato D, Vega R, Viviers E, Morris C, Bradfield S, Gibbs C, et al.
Int J Radiat Oncol Biol Phys . 2022 Feb; 113(2):345-354. PMID: 35176415
Purpose: Owing to adjacent critical organs, the aggressive multimodality local therapy necessary for Ewing sarcoma of the chest wall is a challenge. Our previous review of historical outcomes at our...
8.
Indelicato D, Vega R, Viviers E, Morris C, Bradfield S, Ranalli N, et al.
Int J Radiat Oncol Biol Phys . 2022 Jan; 113(1):161-165. PMID: 35033584
Purpose: In 2010, we published a comprehensive review of our institutional outcomes about treating children with spinal and paraspinal Ewing sarcoma using photon therapy. Multimodality therapy was associated with fair...
9.
Uezono H, Indelicato D, Rotondo R, Vega R, Bradfield S, Morris C, et al.
Int J Radiat Oncol Biol Phys . 2020 May; 107(5):974-981. PMID: 32437922
Purpose: Ewing sarcoma of the pelvis is associated with inferior local control compared with those arising from other primary sites. Despite its increased use, outcome data for treatment with proton...
10.
Ruland M, Egelund T, Ng J, Bradfield S, Egelund E
J Pediatr Pharmacol Ther . 2019 Nov; 24(6):528-533. PMID: 31719815
Posaconazole is a lipophilic triazole antifungal that exhibits variable absorption when administered orally. It possesses a broad spectrum of activity against various fungi, such as Aspergillus and traditionally resistant molds...